Feline Toxoplasmosis: Public Health Implications, Clinical Presentation, and Diagnostic Management
Etiology and Life Cycle
Feline toxoplasmosis is caused by the obligate intracellular apicomplexan parasite Toxoplasma gondii. Felids, including domestic cats, serve as the definitive hosts in which the parasite completes its sexual cycle and produces oocysts [1, 2]. The life cycle involves three infectious stages: tachyzoites (rapidly dividing), bradyzoites (slowly dividing within tissue cysts), and sporozoites (within sporulated oocysts) [1, 3]. Cats become infected primarily through ingestion of tissue cysts containing bradyzoites in intermediate hosts (e.g., rodents, birds) or through ingestion of sporulated oocysts from the environment [2, 4]. After ingestion, bradyzoites excyst in the small intestine and invade enterocytes, initiating the enteroepithelial cycle that culminates in the production of unsporulated oocysts [1, 5]. Oocyst shedding begins 3 to 10 days post-infection and can last 1 to 3 weeks, with a single cat shedding millions of oocysts [1, 2]. Sporulation in the environment renders oocysts infectious to all warm-blooded animals, including humans [1, 2].
Epidemiology and Public Health Implications
T. gondii is a globally distributed zoonotic parasite, and seroprevalence in feline populations varies widely by geographic region, management practices, and diagnostic methodology [6, 7, 8]. A seroprevalence study in Kuwait reported 60% IgG and 31.7% IgM seropositivity among 120 cats using immunochromatographic assays [6]. In Greece, a nationwide study of 1554 cats found 21.8% seropositivity, with significantly higher rates in rural cats, cats with outdoor access, and hunting cats [7]. In Brazil, seroprevalence in Teresina, Piauí, was reported at 57.14% among cats with ocular lesions [9]. In Finland, a study of 249 cats found a seroprevalence of 47.4% using a commercial ELISA [10]. In Japan, a survey in Saitama Prefecture reported 11.8% seropositivity among 220 cats [11]. In the United States, early studies found 37.5% seropositivity in adult domiciled cats and 57.9% in adult stray cats [4]. In Russia, a study in Perm reported an epizootiological prevalence of 32.5% [12].
The public health significance of feline toxoplasmosis is profound because cats are the only source of environmentally resistant oocysts that contaminate soil, water, and food [1, 2]. Human infection occurs through ingestion of oocysts from contaminated sources or consumption of undercooked meat containing tissue cysts [2]. The term "toxoplasmosis cat lady disease" has emerged in popular discourse, often conflating cat ownership with toxoplasmosis risk. However, epidemiological evidence indicates that the primary risk factors for human infection are consumption of undercooked meat and poor hand hygiene during gardening, not simply cat ownership [7, 13]. Risk factors for feline infection include outdoor access, hunting behavior, raw feeding, and stray or feral status [7, 13, 14]. Coinfection with feline immunodeficiency virus (FIV) or feline leukemia virus (FeLV) increases the risk of clinical toxoplasmosis in cats [15, 16, 14, 17].
Clinical Presentation
Clinical feline toxoplasmosis is less common than seropositivity suggests, with most infected cats remaining asymptomatic [18, 19]. Clinical disease occurs more frequently in immunocompromised cats, including those with FIV, FeLV, or those receiving immunosuppressive therapy [15, 16, 17]. A case report described fatal disseminated toxoplasmosis in an FIV-positive cat receiving oclacitinib for feline atopic skin syndrome [15]. Another report documented cerebral toxoplasmosis in a cat coinfected with FeLV and feline infectious peritonitis virus [17].
Clinical signs are referable to the organ systems affected. Ocular toxoplasmosis is a common manifestation, presenting as anterior uveitis, posterior segment involvement (chorioretinitis), or both [9]. In a study of 60 seropositive cats with ocular signs, 63.33% had anterior uveitis, 20% had posterior segment involvement, and 8.33% had anterior uveitis with anterior chamber abnormalities [9]. Respiratory signs include dyspnea, tachypnea, and pneumonia due to tachyzoite proliferation in pulmonary tissue [16]. Neurological signs include seizures, ataxia, circling, and behavioral changes, reflecting encephalitis or meningoencephalitis [17]. Gastrointestinal signs such as anorexia, vomiting, diarrhea, and icterus may occur [20, 16]. Systemic signs include fever, lethargy, and emaciation [16]. Hematological abnormalities include regenerative anemia in immunocompetent cats and non-regenerative anemia in immunocompromised cats, as well as lymphopenia and neutrophilia [20, 16]. Biochemical abnormalities include elevated liver enzymes (ALT, AST) and hyperbilirubinemia, indicating hepatic involvement [20].
Pathology
Gross and histopathological lesions reflect the cytolytic and inflammatory effects of tachyzoite proliferation. In the lungs, interstitial pneumonia with alveolar edema and fibrin exudation is observed [21]. In the liver, multifocal necrotic hepatitis with intralesional tachyzoites is common [21]. In the central nervous system, necrotizing encephalitis with gliosis, perivascular cuffing, and intralesional tachyzoites or tissue cysts is characteristic [21, 17]. Ocular pathology includes granulomatous chorioretinitis, anterior uveitis, and retinal necrosis [9]. In immunocompromised cats, lesions are more severe and disseminated [15, 17].
Diagnostic Management
Accurate diagnosis of feline toxoplasmosis requires a combination of serological, molecular, and clinical approaches [1, 22]. The diagnostic workflow is summarized in the decision tree below.
graph TD
A[Cat with clinical signs suggestive of toxoplasmosis], > B{Serological testing}
B, > C[IgM and IgG ELISA or immunochromatographic assay]
C, > D{IgM positive, IgG negative or low}
D, > E[Suggestive of acute/active infection]
C, > F{IgG positive, IgM negative}
F, > G[Suggestive of chronic/latent infection]
C, > H{IgM and IgG positive}
H, > I[Suggestive of recent infection or reactivation]
C, > J{Both negative}
J, > K[Active infection unlikely; consider other diagnoses]
E, > L{Confirm with PCR on blood, CSF, or aqueous humor}
G, > M{Clinical signs consistent?}
M, > N[Consider PCR or histopathology for definitive diagnosis]
I, > L
L, > O[PCR positive: confirm active infection]
L, > P[PCR negative: active infection less likely]
O, > Q[Initiate antiprotozoal therapy]
Q, > R[Monitor clinical response and serology]
Serological Assays
Serological detection of anti-T. gondii antibodies is the most common diagnostic approach [1, 22]. Immunoglobulin G (IgG) antibodies indicate prior exposure and chronic infection, while immunoglobulin M (IgM) antibodies suggest recent or active infection [6, 9]. Commercial ELISA kits and immunochromatographic assays are widely used [6, 23]. The latex agglutination test (LAT) is a reference method for IgG detection [23]. A study evaluating recombinant antigens in IgG ELISA found that tachyzoite lysate antigen (TLA) showed 94.27% concordance with LAT, and a combination of SAG2 and dense granule proteins (GRA2, GRA6, GRA7, GRA15) achieved similar performance [23].
Recent research has identified micronemal protein 17A (MIC17A) as a novel diagnostic marker for feline toxoplasmosis [5, 24]. MIC17A is abundantly expressed in merozoites, the stage responsible for oocyst production in the feline intestine [5]. In contrast, antigens highly expressed in tachyzoites (e.g., GRA1, MIC3) react poorly with feline IgG [5]. MIC17A shows potential as both an enteroepithelial and chronic stage marker, enabling detection of cats actively shedding oocysts [5, 24].
Molecular Diagnostics
Polymerase chain reaction (PCR) assays detect T. gondii DNA in blood, cerebrospinal fluid (CSF), aqueous humor, bronchoalveolar lavage fluid, or tissue biopsies [1]. PCR is particularly useful for confirming active infection when serology is equivocal [1]. Quantitative PCR (qPCR) can provide parasite load estimates [1]. Emerging technologies include nanomaterial-enhanced biosensors and artificial intelligence-driven diagnostic algorithms that may improve sensitivity and stage-specific detection [1].
Hematology and Biochemistry
Complete blood count (CBC) and serum biochemistry are supportive but not diagnostic. Common findings include anemia (regenerative or non-regenerative), lymphopenia, neutrophilia, elevated ALT and AST, and hyperbilirubinemia [20, 16]. In cats with coronavirus infection complicated by toxoplasmosis, more pronounced hepatic enzyme elevations and anemia were observed [20].
Advanced Diagnostics
In cases of ocular toxoplasmosis, analysis of aqueous humor for anti-T. gondii antibodies (Goldmann-Witmer coefficient) or PCR can confirm intraocular infection [9]. For neurological cases, CSF analysis may show elevated protein and mononuclear pleocytosis, and PCR on CSF can detect parasite DNA [17]. Histopathology with immunohistochemistry remains the gold standard for postmortem diagnosis [21, 17].
Treatment
Treatment is indicated for cats with clinical toxoplasmosis, particularly those with ocular, respiratory, or neurological signs [9, 25, 16]. The standard therapeutic regimen includes clindamycin (10-12 mg/kg orally every 12 hours for 4 weeks) [9, 25]. Alternative drugs include trimethoprim-sulfonamide combinations and pyrimethamine combined with sulfadiazine [20, 9]. In a study of 60 cats with ocular toxoplasmosis treated with clindamycin and topical therapy, 46.7% showed complete response, 41.7% showed partial response, and 11.6% showed poor response [9]. Immunocompetent cats generally respond well to therapy, while immunocompromised cats (e.g., FIV-positive) have a poorer prognosis [15, 16]. Adjunctive therapy with immunomodulators such as polyprenyl phosphate has been used in cats with concurrent coronavirus infection [20].
Control and Prevention
Control of feline toxoplasmosis focuses on reducing environmental oocyst contamination and preventing infection in cats [1, 2]. Key measures include keeping cats indoors to prevent hunting, feeding commercial cooked or canned food rather than raw meat, and prompt removal of feces from litter boxes (within 24 hours before oocysts sporulate) [2, 13]. Pregnant women and immunocompromised individuals should avoid handling cat litter and should practice rigorous hand hygiene after gardening or contact with soil [2]. Routine serological screening of cats is not recommended for public health purposes, as seropositive cats are unlikely to be actively shedding oocysts [22]. However, diagnostic testing is essential for cats with clinical signs consistent with toxoplasmosis [1, 22].
References
[1] Dan Zhao, Yanzhen Liao, Hao Liu et al. Comprehensive diagnostic approaches to feline toxoplasmosis: Bridging traditional methods and emerging technologies. Virulence, 2025. URL: https://www.semanticscholar.org/paper/2e757aa2ddd10827f80fab2653e009ad1d5e71da
[2] K. Bresciani, A. L. Galvão, A. L. D. Vasconcellos et al. EPIDEMIOLOGICAL ASPECTS OF FELINE TOXOPLASMOSIS. Journal, 2016. URL: https://www.semanticscholar.org/paper/6b9f21d91d91295b742aef77632d2525479580ce
[3] J. P. Dubey, J. K. Frenkel. Feline toxoplasmosis from acutely infected mice and the development of Toxoplasma cysts. The Journal of Protozoology, 1976. URL: https://www.semanticscholar.org/paper/8baf73ffc19ee8034b04927ed5eb249b3daa9e18
[4] J. Dubey. Feline toxoplasmosis and coccidiosis: a survey of domiciled and stray cats. Journal of the American Veterinary Medical Association, 1973. URL: https://www.semanticscholar.org/paper/ccb8d11ca9bbfc79aec59433b8a97df0159136cd
[5] Jinling Chen, Lilan Xue, Hongxia Hu et al. MIC17A is a novel diagnostic marker for feline toxoplasmosis. Animal Diseases, 2022. URL: https://www.semanticscholar.org/paper/409a1c77abdc8102e0ee7ad5b4a222f8efdd3e71
[6] S. M. Ibrahim, I. Mohamed, S. E. Suliman et al. Seroprevalence of Feline Toxoplasmosis in Kuwait State. International Journal of Current Microbiology and Applied Sciences, 2025. URL: https://www.semanticscholar.org/paper/f05f6b05b012c996ed244740c03869e7e95c3f5b
[7] G. Sioutas, I. Symeonidou, A. Gelasakis et al. Feline Toxoplasmosis in Greece: A Countrywide Seroprevalence Study and Associated Risk Factors. Pathogens, 2022. URL: https://www.semanticscholar.org/paper/7a38aa6feab78b556c75fca605f426eadd8440c6
[8] J. Teixeira, Jéssica S Oliveira, D. Almeida et al. Seroprevalence of feline toxoplasmosis in Teresina, Piauí, Brazil. Journal, 2016. URL: https://www.semanticscholar.org/paper/b5a75e8076e477c63e0ad3cf290165adcea31440
[9] K. M. Ali, A. M. Abu-Seida, M. Abuowarda. Feline ocular toxoplasmosis: seroprevalence, diagnosis and treatment outcome of 60 clinical cases. Polish Journal of Veterinary Sciences, 2021. URL: https://www.semanticscholar.org/paper/0d19fc80bf1bde129d6b11a3e14b5e0b7dc7192c
[10] P. Jokelainen, O. Simola, E. Rantanen et al. Feline toxoplasmosis in Finland. Journal of Veterinary Diagnostic Investigation, 2012. URL: https://www.semanticscholar.org/paper/6a4fbacb25ee047707fcc3cc04c3c600dc321216
[11] K. Mizusawa, K. Oosawa, K. Thoyama et al. Seroepidemiological Survey on Feline Toxoplasmosis in Saitama Prefecture. Journal, 1991. URL: https://www.semanticscholar.org/paper/c614f887ae21d3ca12a82fdee2f1537273f48508
[12] T. Sivkova, A. Shchukina. [The epizootology of feline toxoplasmosis in the town of Perm]. Meditsinskaia Parazitologiia i Parazitarnye Bolezni, 2008. URL: https://www.semanticscholar.org/paper/676184d88f61d78d65e2295dde6078cb8874f7e8
[13] A. Brennan. Risk factors in feline toxoplasmosis. Journal, 2018. URL: https://www.semanticscholar.org/paper/f488897999e2e89707722c6d17b4288f318c47a5
[14] A. Munhoz, Samir Batista Hage, R. Cruz et al. Toxoplasmosis in cats in northeastern Brazil: Frequency, associated factors and coinfection with Neospora caninum, feline immunodeficiency virus and feline leukemia virus. Veterinary Parasitology: Regional Studies and Reports, 2017. URL: https://www.semanticscholar.org/paper/7c8a2fdd2e9561c2569bc4e98397bbe347e630a2
[15] A. Moore, A. Burrows, R. Malik et al. Fatal disseminated toxoplasmosis in a feline immunodeficiency virus-positive cat receiving oclacitinib for feline atopic skin syndrome. Veterinary Dermatology, 2022. URL: https://www.semanticscholar.org/paper/c931267329077e9f22210c3439872dddff053542
[16] E. A. Okewole, M. O. Akpan. Clinical feline toxoplasmosis: parasitological, haematological and serological findings in retroviral infected and uninfected cats. Journal, 2002. URL: https://www.semanticscholar.org/paper/2e27851bb71e0ccb0409282c54991b0237af3d91
[17] L. Zandonà, R. Brunetta, C. Zanardello et al. Cerebral toxoplasmosis in a cat with feline leukemia and feline infectious peritonitis viral infections. The Canadian Veterinary Journal, 2018. URL: https://www.semanticscholar.org/paper/9b883ef30868dedf42a1c8dc0e77da44df0abb2
[18] S. Caney. Update on feline toxoplasmosis. Journal, 2021. URL: https://www.semanticscholar.org/paper/04388a62c4aa2e740b6e424bd443e7a1366da8e9
[19] M. Lappin, C. Greene, S. Winston et al. Clinical Feline Toxoplasmosis. Journal, 1989. URL: https://www.semanticscholar.org/paper/1ae2d5c4420cf0ff662e99d9964dc6c34a70036b
[20] S. Savoyskaya, A. Sanin, I. Ogorodnikova et al. Phosprenyl usage as part of the complex therapy of feline chronic coronavirus infection complicated by toxoplasmosis. Russian Veterinary Journal, 2022. URL: https://www.semanticscholar.org/paper/d2205256d3e3592683ec54c4e85a619eac09add0
[21] R. Hirth, S. W. Nielsen. Pathology of feline toxoplasmosis. Journal of Small Animal Practice, 1969. URL: https://www.semanticscholar.org/paper/70ea7aed2b1cd57cf4238050c1395234eaa98dde
[22] M. R. Lappin. Feline toxoplasmosis: interpretation of diagnostic test results. Seminars in Veterinary Medicine and Surgery, 1996. URL: https://www.semanticscholar.org/paper/0ebd1635960c3958e8d9abd8d2646094a8be6fd8
[23] A. Abdelbaset, Hend Alhasan, Doaa Salman et al. Evaluation of recombinant antigens in combination and single formula for diagnosis of feline toxoplasmosis. Experimental Parasitology, 2017. URL: https://www.semanticscholar.org/paper/1fd2239858e29ce336d8d273dd32e3c1ed51f467
[24] Özlem Günay-Esiyok, Ecem Su Koçkaya, Rana Yılmaz et al. The Potential of MIC17A both as an Entero-epithelial and Chronic Stage Marker for Detection of Feline Toxoplasmosis. Current Microbiology, 2026. URL: https://www.semanticscholar.org/paper/170f603aa98f7dd6b215d4a83f5f76f844c9e861
[25] M. Lappin, C. Greene, S. Winston et al. Clinical feline toxoplasmosis. Serologic diagnosis and therapeutic management of 15 cases. Journal of Veterinary Internal Medicine, 1989. URL: https://www.semanticscholar.org/paper/188e9c3e7b48fcd3dd733c4dadbdd3bf4a2c1d80
[26] J. L. Faria, C. Couto, Sheron L Wierzynski et al. Feline Toxoplasmosis: Tumor Necrosis Factor, Nitric Oxide, and Free Radicals in Seropositive Cats. Journal of Parasitology, 2018. URL: https://www.semanticscholar.org/paper/6949c8c0034df3c74f48a543ed58094bbdee2c85
[27] J. Dubey, J. K. Frenkel. Immunity to Feline Toxoplasmosis: Modification by Administration of Corticosteroids. Veterinary Pathology-Supplement, 1974. URL: https://www.semanticscholar.org/paper/7d02cb1226cf6abea11de16a6dd851250bc20241
[28] M. Petrak, J. Carpenter. FELINE TOXOPLASMOSIS. Journal of the American Veterinary Medical Association, 1965. URL: https://www.semanticscholar.org/paper/b716bfc934da864c863f7e5d8c3624e2dcc7c73e
[29] Y. Omata, H. Oikawa, M. Kanda et al. Experimental feline toxoplasmosis: humoral immune responses of cats inoculated orally with Toxoplasma gondii cysts and oocysts. Nihon Juigaku Zasshi. The Japanese Journal of Veterinary Science, 1990. URL: https://www.semanticscholar.org/paper/b51652947e0dfa715c4d08df67cd76221708e926
[30] MacKnight Kt, Robinson Hw. Epidemiologic studies on human and feline toxoplasmosis. Journal, 1992. URL: https://www.semanticscholar.org/paper/1f00a302a974f5cfc4ddec180eb6d4e0e52698df
[31] J. Dubey. Feline toxoplasmosis and its nematode transmission. Journal, 1968. URL: https://www.semanticscholar.org/paper/9739e9c0ebc5b4da8a73d718ce795f65831c9bd1
[32] S. P. Pakes, W. Lai. Carbon immunoassay-a simple and rapid serodiagnostic test for feline toxoplasmosis. Laboratory Animal Science, 1985. URL: https://www.semanticscholar.org/paper/080360020a814df09eb4c1d8667765bf1f9c6448
[33] M. Svoboda, J. Konrád, V. Svobodová. [Diagnosis and prevention of feline toxoplasmosis]. Tierarztliche Praxis, 1988. URL: https://www.semanticscholar.org/paper/0c47806d4447df5d683949639d6bc30766a7b03b
[34] T. Hagiwara, Y. Katsube, T. Muto et al. Experimental feline toxoplasmosis. Nihon Juigaku Zasshi. The Japanese Journal of Veterinary Science, 1981. URL: https://www.semanticscholar.org/paper/4a9f71a86da7f23dbac805ed17582f5d491c5498
[35] M. Lappin. Chapter 28. Feline Toxoplasmosis. Journal, 2008. URL: https://www.semanticscholar.org/paper/0d5233dd99e8824d4e4e00369f97cc6b0491eefa *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.